See more : OneMedNet Corporation (ONMD) Income Statement Analysis – Financial Results
Complete financial analysis of Onyx Healthcare Inc. (6569.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Onyx Healthcare Inc., a leading company in the Healthcare industry within the Healthcare sector.
- PT Agung Semesta Sejahtera Tbk (TARA.JK) Income Statement Analysis – Financial Results
- Ahren Acquisition Corp. (AHRN) Income Statement Analysis – Financial Results
- Dongjiang Environmental Company Limited (0895.HK) Income Statement Analysis – Financial Results
- Luminex Resources Corp. (LUMIF) Income Statement Analysis – Financial Results
- Jay Ushin Limited (JAYUSH.BO) Income Statement Analysis – Financial Results
Onyx Healthcare Inc. (6569.TWO)
About Onyx Healthcare Inc.
Onyx Healthcare Inc., a professional medical IT company, engages in the design, manufacturing, and trading of medical computers and peripherals for hospital/clinical IT market in Taiwan. The company offers AI ready medical PC and tablet, medical PC and monitor for digital OR, telemedicine, medical cart computer, medical power panel PC, power bank, battery management system, mobile medical tablet, professional and slim medical all in one PC, medical display and computer for medical devices, powerful medical all in one PC, motherboard, and industrial PC and tablet products, as well as healthcare infotainment all in one computer products. It also provides ODM/OEM services. The company was incorporated in 2010 and is headquartered in New Taipei City, Taiwan. Onyx Healthcare Inc. operates as a subsidiary of AAEON Technology Inc.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.49B | 1.60B | 1.20B | 1.35B | 1.48B |
| Cost of Revenue | 936.72M | 1.13B | 838.03M | 883.30M | 940.30M |
| Gross Profit | 556.14M | 472.31M | 363.73M | 464.01M | 542.64M |
| Gross Profit Ratio | 37.25% | 29.51% | 30.27% | 34.44% | 36.59% |
| Research & Development | 79.36M | 86.67M | 79.35M | 68.64M | 68.97M |
| General & Administrative | 77.32M | 79.23M | 69.21M | 70.20M | 68.56M |
| Selling & Marketing | 181.66M | 162.36M | 139.76M | 161.96M | 157.06M |
| SG&A | 258.66M | 241.59M | 208.96M | 232.16M | 237.05M |
| Other Expenses | 0.00 | 36.28M | 17.90M | 7.86M | 0.00 |
| Operating Expenses | 338.02M | 328.26M | 288.32M | 300.79M | 306.02M |
| Cost & Expenses | 1.27B | 1.46B | 1.13B | 1.18B | 1.25B |
| Interest Income | 2.99M | 981.00K | 137.00K | 665.00K | 1.45M |
| Interest Expense | 3.68M | 3.56M | 2.63M | 476.00K | 1.26M |
| Depreciation & Amortization | 24.10M | 26.83M | 27.04M | 30.23M | 14.68M |
| EBITDA | 332.78M | 271.07M | 170.68M | 235.87M | 251.31M |
| EBITDA Ratio | 22.29% | 16.94% | 14.20% | 17.51% | 16.95% |
| Operating Income | 218.12M | 244.24M | 143.65M | 205.64M | 236.63M |
| Operating Income Ratio | 14.61% | 15.26% | 11.95% | 15.26% | 15.96% |
| Total Other Income/Expenses | 86.88M | 96.64M | 65.60M | 41.95M | 53.28M |
| Income Before Tax | 305.00M | 242.03M | 140.11M | 202.61M | 289.91M |
| Income Before Tax Ratio | 20.43% | 15.12% | 11.66% | 15.04% | 19.55% |
| Income Tax Expense | 49.83M | 38.90M | 13.60M | 37.71M | 54.38M |
| Net Income | 255.26M | 202.96M | 127.55M | 167.08M | 239.38M |
| Net Income Ratio | 17.10% | 12.68% | 10.61% | 12.40% | 16.14% |
| EPS | 6.66 | 5.43 | 3.67 | 4.74 | 6.88 |
| EPS Diluted | 6.60 | 5.39 | 3.65 | 4.71 | 6.85 |
| Weighted Avg Shares Out | 38.35M | 37.40M | 34.33M | 35.27M | 34.96M |
| Weighted Avg Shares Out (Dil) | 38.69M | 37.63M | 34.48M | 35.47M | 34.95M |
Source: https://incomestatements.info
Category: Stock Reports